BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16003225)

  • 1. "Prope" tolerance: induction, lymphocyte depletion with minimal maintenance.
    Calne R
    Transplantation; 2005 Jul; 80(1):6-7. PubMed ID: 16003225
    [No Abstract]   [Full Text] [Related]  

  • 2. Steroid-free lymphocyte depletion protocols. The potential for partial tolerance?
    McCauley J
    Contrib Nephrol; 2005; 146():43-53. PubMed ID: 15567919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphocyte depletion as a barrier to immunological tolerance.
    Neujahr D; Turka LA
    Contrib Nephrol; 2005; 146():65-72. PubMed ID: 15567921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human donor bone marrow cells can enhance hyporeactivity in renal transplantation using maintenance FK 506 and OKT3 induction therapy.
    Ciancio G; Carreno M; Mathew J; Ricordi C; Garcia R; Karatzas T; Fuller L; Cirocco R; Burke G; Webb M; Nery J; Tzakis A; Roth D; Esquenazi V; Miller J
    Transplant Proc; 1996 Apr; 28(2):943-4. PubMed ID: 8623473
    [No Abstract]   [Full Text] [Related]  

  • 5. T-cell depletion for transplant tolerance induction: promises and hurdles.
    Dumont FJ
    Curr Opin Investig Drugs; 2003 Nov; 4(11):1275-8. PubMed ID: 14758765
    [No Abstract]   [Full Text] [Related]  

  • 6. Mixed chimerism approach to induction of transplant tolerance: a review of the Massachusetts General Hospital experience.
    Saidman SL
    Transplant Proc; 2007 Apr; 39(3):676-7. PubMed ID: 17445571
    [No Abstract]   [Full Text] [Related]  

  • 7. Operational tolerance after immunosuppressive withdrawal in a case with renal transplantation.
    Inal S; Erten Y; Oneç K; Ebinç FA; Arinsoy T
    South Med J; 2011 Jan; 104(1):74. PubMed ID: 21119561
    [No Abstract]   [Full Text] [Related]  

  • 8. Transplantation tolerance. A complex scenario awaiting clinical applicability.
    Sayegh MH; Perico N; Remuzzi G
    Contrib Nephrol; 2005; 146():95-104. PubMed ID: 15567924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Costimulatory blockade for induction of mixed chimerism and renal allograft tolerance in nonhuman primates.
    Kawai T; Abrahamian G; Sogawa H; Wee S; Boskovic S; Andrew D; Nadazdin O; Mauiyyedi S; Weymouth D; Ko D; Colvin R; Sachs D; Cosimi A
    Transplant Proc; 2001; 33(1-2):221-2. PubMed ID: 11266787
    [No Abstract]   [Full Text] [Related]  

  • 10. Reviewing the mechanism of peripheral tolerance in clinical transplantation.
    Suciu-Foca N; Cortesini R
    Contrib Nephrol; 2005; 146():132-142. PubMed ID: 15567927
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of skin grafting to demonstrate tolerance before kidney transplantation without immunosuppression in the recipient of a previous bone marrow transplant.
    Ravanan R; Dudley CR; Smith RM; Burton CJ; Lear PA; Unsworth DJ
    Transplantation; 2005 Feb; 79(3):375-6. PubMed ID: 15699775
    [No Abstract]   [Full Text] [Related]  

  • 12. Prope tolerance: is it the end or the means?
    Morrissey PE
    Transplantation; 2009 Jun; 87(11):1750-1. PubMed ID: 19502973
    [No Abstract]   [Full Text] [Related]  

  • 13. Development of tolerogenic strategies in the clinic.
    Knechtle SJ
    Philos Trans R Soc Lond B Biol Sci; 2005 Sep; 360(1461):1739-46. PubMed ID: 16147538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerance and near-tolerance strategies in monkeys and their application to human renal transplantation.
    Knechtle SJ; Hamawy MM; Hu H; Fechner JH; Cho CS
    Immunol Rev; 2001 Oct; 183():205-13. PubMed ID: 11782258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerance and chimerism after renal and hematopoietic-cell transplantation.
    Scandling JD; Busque S; Dejbakhsh-Jones S; Benike C; Millan MT; Shizuru JA; Hoppe RT; Lowsky R; Engleman EG; Strober S
    N Engl J Med; 2008 Jan; 358(4):362-8. PubMed ID: 18216356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrochimerism and clinical transplant tolerance.
    Scandling JD; Busque S; Lowsky R; Shizuru J; Shori A; Engleman E; Jensen K; Strober S
    Hum Immunol; 2018 May; 79(5):266-271. PubMed ID: 29330112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results from a human renal allograft tolerance trial evaluating T-cell depletion with alemtuzumab combined with deoxyspergualin.
    Kirk AD; Mannon RB; Kleiner DE; Swanson JS; Kampen RL; Cendales LK; Elster EA; Wakefield T; Chamberlain C; Hoffmann SC; Hale DA
    Transplantation; 2005 Oct; 80(8):1051-9. PubMed ID: 16278585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of kidney graft acceptance by creating a window of opportunity for immunologic engagement (WOFIE) in rhesus monkeys.
    Jonker M; Slingerland W; Ossevoort M; Kuhn E; Neville D; Friend P; Calne R
    Transplant Proc; 1998 Aug; 30(5):2441-3. PubMed ID: 9723530
    [No Abstract]   [Full Text] [Related]  

  • 19. In utero induction of transplantation tolerance.
    Mathes DW; Yamada K; Randolph MA; Utsugi R; Solari MG; Gazelle GS; Wu A; Sachs DH; Lee WP
    Transplant Proc; 2001; 33(1-2):98-100. PubMed ID: 11266726
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of horse antithymocyte globulin with other T cell-depleting antibodies for induction of chimerism and renal allograft tolerance in nonhuman primates.
    Sogawa H; Kawai T; Wee SL; Boskovic S; Nadazdin O; Phelan J; Abrahamian G; Ko DS; Hong H; Mauiyyedi S; Colvin RB; Sachs DH; Cosimi AB
    Transplant Proc; 2001; 33(1-2):116-7. PubMed ID: 11266735
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.